Biological E. to invest ₹1,800 crore in Hyderabad expansion

Biological E. announced an investment of ₹1,800 crore to expand manufacturing capacity at three facilities in Genome Valley, Hyderabad. The expansion will add 5 billion doses of vaccine capacity and create 2,518 jobs.

“The investment will be focused on manufacturing of Janssen Covid vaccine, MR Vaccine, PCV Vaccine, Typhoid Vaccine, Covid Vaccine, Tetanus Toxide Ampoules, IPV Vaccine and Pertussis Vaccine, biological APIs and formulations, speciality generic injectables and R&D projects with a cumulative investmen”thehindu.com

• 1 source
• thehindu.comBiological E. to invest ₹1,800 crore in Hyderabad’s Genome Valley - The HinduN. Ravi KumarJul 21, 2022

Summarized from public sources; check the original articles before acting on it.